Estrogen signalling in the pathogenesis of age-related macular degeneration

Current Eye Research

Volumn 40, Issue 2, 2015, Pages 226-233

  Kaarniranta, Kai ^a,b   Machalińska, Anna ^c   Veréb, Zoltán ^d   Salminen, Antero ^a,b   Petrovski, Goran ^d,e,f   Kauppinen, Anu ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c POMERANIAN MEDICAL UNIVERSITY   (Poland)

^d UNIVERSITY OF DEBRECEN   (Hungary)

^e UNIVERSITY OF DEBRECEN   (Hungary)

^f UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Degeneration; Estrogen; Inflammation; Macula; Oxidative stress; Retina

Indexed keywords

ESTROGEN;

AGE RELATED MACULAR DEGENERATION; ASSOCIATION; CLINICAL FEATURE; DISEASE ASSOCIATION; EPITHELIUM CELL; HORMONAL THERAPY; HUMAN; INFLAMMATION; MENOPAUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RETINA CELL; REVIEW; FEMALE; MACULAR DEGENERATION; MALE; METABOLISM; PHYSIOLOGY; RETINA; SIGNAL TRANSDUCTION;

ESTROGENS; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; OXIDATIVE STRESS; RETINA; SIGNAL TRANSDUCTION;

EID: 84921677833     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2014.925933     Document Type: Review

References (95)

1. Kaarniranta K, Sinha D, Blasiak J, Kauppinen A, Vereb Z, Salminen A, et al. Autophagy and heterophagy dysregulation leads to retinal pigment epithelium dysfunction and development of age-related macular degeneration. Autophagy 2013;9:973-984.
2. Eisner A, Stoumbos VD, Klein ML, Fleming SA. Relations between fundus appearance and function. Eyes whose fellow eye has exudative age-related macular degeneration. Invest Ophthalmol Vis Sci 1991;32:8-20.
3. Eisner A, Klein ML, Zilis JD, Watkins MD. Visual function and the subsequent development of exudative age-related macular degeneration. Invest Ophthalmol Vis Sci 1992;33: 3091-3102.
4. Owsley C, McGwin Jr G, Jackson GR, Kallies K, Clark M. Cone-and rod-mediated dark adaptation impairment in age-related maculopathy. Ophthalmology 2007;114: 1728-1735.
5. Dimitrov PN, Robman LD, Varsamidis M, Aung KZ, Makeyeva G, Busija L, et al. Relationship between clinical macular changes and retinal function in age-related macular degeneration. Invest Ophthalmol Vis Sci 2012;53: 5213-5220.
6. Vision 2020. Right to sight. Blindness and visual impairment: Global facts. Available from www.iapb.org\vision-2020\global-facts, 2014.
7. Gordois A, Cutler H, Pezzullo L, Gordon K, Cruess A, Winyard S, et al. An estimation of the worldwide economic and health burden of visual impairment. Glob Public Health 2012;7:465-481.
8. Bhutto I, Lutty G. Understanding age-related macular degeneration (AMD): Relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex. Mol Aspects Med 2012;33: 295-317.
9. Fritsche LG, Chen W, Schu M, Yaspan BL, Yu Y, Thorleifsson G, et al. Seven new loci associated with agerelated macular degeneration. Nat Genet 2013;45:433-439.
10. Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G, et al. Clinical risk factors for age-related macular degeneration: A systematic review and metaanalysis. BMC Ophthalmol 2010;13;10:31.
11. Evans JR. Risk factors for age-related macular degeneration. Prog Retin Eye Res 2001;20:227-253.
12. Mitchell P, Wang JJ, Foran S, Smith W. Five-year incidence of age-related maculopathy lesions: The Blue Mountains Eye Study. Ophthalmology 2002;109:1092-1097.
13. Seddon JM, Cote J, Rosner B. Progression of age-related macular degeneration: Association with dietary fat, transunsaturated fat, nuts and fish intake. Arch Ophthalmol 2003;121:1728-1737.
14. Cho E, Hung S, Willett WC, Spiegelman D, Rimm EB, Seddon JM, et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr 2001;73:209-218.
15. Seddon JM, George S, Rosner B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: The US Twin Study of Age-Related Macular Degeneration. Arch Ophthalmol 2006;124:995-1001.
16. Seddon JM, Rosner B, Sperduto RD, Yannuzzi L, Haller JA, Blair NP, et al. Dietary fat and risk for advanced agerelated macular degeneration. Arch Ophthalmol 2001;119: 1191-1199.
17. SanGiovanni JP, Chew EY, Clemons TE, Davis MD, Ferris 3rd FL, Gensler GR, et al. The relationship of dietary lipid intake and age-related macular degeneration in a casecontrol study: AREDS Report No.rt Arch Ophthalmol 2007;125:671-679.
18. Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A, Owen CG. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: A meta-analysis. Ophthalmology 2012; 119:571-580.
19. Ying GS, Maguire MG, Alexander J, Martin RW, Antoszyk AN; Complications of Age-related Macular Degeneration Prevention Trial Research Group. Description of the Age-Related Eye Disease Study 9-step severity scale applied to participants in the Complications of Age-related Macular Degeneration Prevention Trial. Arch Ophthalmol 2009;127: 1147-1151.
20. Klein BE, Klein R, Jensen SC, Ritter LL. Are sex hormones associated with age-related maculopathy in women? The Beaver Dam Eye Study. Trans Am Ophthalmol Soc 1994;92: 289-295.
21. Cui J, Shen Y, Li R. Estrogen synthesis and signalling pathways during aging: From periphery to brain. Trends Mol Med 2013;19:197-209.
22. Chang JR, Koo E, Agron E, Hallak J, Clemons T, Azar D, et al. Risk factors associated with incident cataracts and cataract surgery in the Age-related Eye Disease Study (AREDS): AREDS report number. Ophthalmology 2011; 118:2113-2119.
23. Wong TY. Age-related macular degeneration: Why should stroke physicians care? Stroke 2010;41:575-576.
24. Petrea RE, Beiser AS, Seshadri S, Kelly-Hayes M, Kase CS, Wolf PA. Gender differences in stroke incidence and poststroke disability in the Framingham heart study. Stroke 2009;40:1032-1037.
25. Hu CC, Ho JD, Lin HC. Neovascular age-related macular degeneration and the risk of stroke: A 5-year populationbased follow-up study. Stroke. 2010;41:613-617.
26. Khosla S, Atkinson EJ, Melton 3rd LJ, Riggs BL. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: A population-based study. J Clin Endocrinol Metab 1997;82:1522-1527.
27. Seitzman RL, Mangione CM, Cauley JA, Ensrud KE, Stone KL, Cummings SR, et al.; Study of Osteoporotic Fractures Research Group. Bone mineral density and age-related maculopathy in older women. J Am Geriatr Soc 2007;55: 740-746.
28. Ascenzi P, Bocedi A, Marino M. Structure-function relationship of estrogen receptor alpha and beta: Impact on human health. Mol Aspects Med 2006;27:299-402.
29. Marin-Castano ME, Elliot SJ, Potier M, Karl M, Striker LJ, Striker GE, et al. Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. Invest Ophthalmol Vis Sci 2003;44:50-59.
30. Nishihara E, Nagayama Y, Inoue S, Hiroi H, Muramatsu M, Yamashita S, et al. Ontogenetic changes in the expression of estrogen receptor alpha and beta in rat pituitary gland detected by immunohistochemistry. Endocrinology 2000;141:615-620.
31. Ogueta SB, Schwartz SD, Yamashita CK, Farber DB. Estrogen receptor in the human eye: Influence of gender and age on gene expression. Invest Ophthalmol Vis Sci 1999;40:1906-1911.
32. Munaut C, Lambert V, Noel A, Frankenne F, Deprez M, Foidart JM, et al. Presence of oestrogen receptor type beta in human retina. Br J Ophthalmol 2001;85:877-882.
33. Harnish DC, Scicchitano MS, Adelman SJ, Lyttle CR, Karathanasis SK. The role of CBP in estrogen receptor cross-talk with nuclear factor-kappaB in HepG2 cells. Endocrinology 2000;141:3403-3411.
34. Harrington WR, Sheng S, Barnett DH, Petz LN, Katzenellenbogen JA, Katzenellenbogen BS. Activities of estrogen receptor alpha-and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol Cell Endocrinol 2003;206: 13-22.
35. Vegeto E, Ciana P, Maggi A. Estrogen and inflammation: Hormone generous action spreads to the brain. Mol Psychiatry 2002;7:236-238.
36. Thomas P, Pang Y, Filardo EJ, Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005;146: 624-632.
37. Feskanich D, Cho E, Schaumberg DA, Colditz GA, Hankinson SE. Menopausal and reproductive factors and risk of age-related macular degeneration. Arch Ophthalmol 2008;126:519-524.
38. Fraser-Bell S, Wu J, Klein R, Azen SP, Varma R. Smoking, alcohol intake, estrogen use, and age-related macular degeneration in Latinos: The Los Angeles Latino Eye Study. Am J Ophthalmol 2006;141:79-87.
39. Freeman EE, Munoz B, Bressler SB, West SK. Hormone replacement therapy, reproductive factors, and age-related macular degeneration: The Salisbury Eye Evaluation Project. Ophthalmic Epidemiol 2005;12:37-45.
40. Defay R, Pinchinat S, Lumbroso S, Sutan C, Delcourt C; Pola Study Group. Sex steroids and age-related macular degeneration in older French women: The POLA study. Ann Epidemiol 2004;14:202-208.
41. Klein BE, Howard KP, Lee KE, Iyengar SK, Sivakumaran TA, Klein R. The relationship of cataract and cataract extraction to age-related macular degeneration: The Beaver Dam Eye Study. Ophthalmology 2012;119:1628-1633.
42. Wang JJ, Fong CS, Rochtchina E, Cugati S, de Loryn T, Kaushik S, et al. Risk of age-related macular degeneration 3 years after cataract surgery: Paired eye comparisons. Ophthalmology 2012;119:2298-2303.
43. Vingerling JR, Dielemans I, Witteman JC, Hofman A, Grobbee DE, de Jong PT. Macular degeneration and early menopause: A case-control study. BMJ 1995;310:1570-1571.
44. Smith W, Mitchell P, Wang JJ. Gender, oestrogen, hormone replacement and age-related macular degeneration: Results from the Blue Mountains Eye Study. Aust N Z J Ophthalmol 1997;25:S13-S15.
45. Snow KK, Cote J, Yang W, Davis NJ, Seddon JM. Association between reproductive and hormonal factors and age-related maculopathy in post-menopausal women. Am J Ophthalmol 2002;134:842-848.
46. Boekhoorn SS, Vingerling JR, Uitterlinden AG, Van Meurs JB, van Duijn CM, Pols HA, et al. Estrogen receptor alpha gene polymorphisms associated with incident aging macula disorder. Invest Ophthalmol Vis Sci 2007;48: 1012-1017.
47. Vinding T, Nielsen NV. Retinopathy caused by treatment with tamoxifen in low dosage. Acta Ophthalmol (Copenh) 1983;61:45-50.
48. Eisner A, Luoh CW. Breast cancer medications and vision: Effects of treatments for early-stage disease. Curr Eye Res 2011;36:867-885.
49. Tamer C, Oksuz H, Sogut S. Serum dehydroepiandrosterone sulphate level in age-related macular degeneration. Am J Ophthalmol 2007;143:212-216.
50. Espinosa-Heidmann DG, Marin-Castano ME, Pereira-Simon S, Hernandez EP, Elliot S, Cousins SW. Gender and estrogen supplementation increases severity of experimental choroidal neovascularization. Exp Eye Res 2005;80: 413-423.
51. Moeinpour F, Choudhry MA, Kawasaki T, Timares L, Schwacha MG, Bland KI, et al. 17 Beta-estradiol normalizes Toll receptor 4, mitogen activated protein kinases and inflammatory response in epidermal keratinocytes following trauma-hemorrhage. Mol Immunol 2007;44:3317-3323.
52. Pfeilschifter J, Koditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002;23:90-119.
53. Tani A, Yasui T, Matsui S, Kato T, Kunimi K, Tsuchiya N, et al. Different circulating levels of monocyte chemoattractant protein-1 and interleukin-8 during the menopausal transition. Cytokine 2013;62:86-90.
54. Zhao R. Immune regulation of osteoclast function in postmenopausal osteoporosis: A critical interdisciplinary perspective. Int J Med Sci 2012;9:825-832.
55. Cheung J, Mak YT, Papaioannou S, Evans BA, Fogelman I, Hampson G. Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: Comparison of the effects of 17-beta oestradiol and raloxifene. J Endocrinol 2003;177:423-433.
56. Koka S, Petro TM, Reinhardt RA. Estrogen inhibits interleukin-1beta-induced interleukin-6 production by human osteoblast-like cells. J Interferon Cytokine Res 1998;18: 479-483.
57. Cuzzocrea S, Santagati S, Sautebin L, Mazzon E, Calabro G, Serraino I, et al. 17 beta-Estradiol anti-inflammatory activity in carrageenan-induced pleurisy. Endocrinology 2000;141:1455-1463.
58. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000;45:115-134.
59. Tretter L, Adam-Vizi V. Alpha-ketoglutarate dehydrogenase: A target and generator of oxidative stress. Philos Trans R Soc Lond B Biol Sci 2005;360:2335-2345.
60. Schutt F, Davies S, Kopitz J, Holz FG, Boulton ME. Photodamage to human RPE cells by A2-E, a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci 2000; 41:2303-2308.
61. Schutt F, Bergmann M, Holz FG, Kopitz J. Proteins modified by malondialdehyde, 4-hydroxynonenal, or advanced glycation end products in lipofuscin of human retinal pigment epithelium. Invest Ophthalmol Vis Sci 2003;44:3663-3668.
62. Kaarniranta K, Ryhanen T, Karjalainen HM, Lammi MJ, Suuronen T, Huhtala A, et al. Geldanamycin increases 4-hydroxynonenal (HNE)-induced cell death in human retinal pigment epithelial cells. Neurosci Lett 2005;382: 185-190.
63. Kaemmerer E, Schutt F, Krohne TU, Holz FG, Kopitz J. Effects of lipid peroxidation-related protein modifications on RPE lysosomal functions and POS phagocytosis. Invest Ophthalmol Vis Sci 2007;48:1342-1347.
64. Vives-Bauza C, Anand M, Shirazi AK, Magrane J, Gao J, Vollmer-Snarr HR, et al. The age lipid A2E and mitochondrial dysfunction synergistically impair phagocytosis by retinal pigment epithelial cells. J Biol Chem 2008;283: 24770-24780.
65. Schmitz-Valckenberg S, Fleckenstein M, Scholl HP, Holz FG. Fundus autofluorescence and progression of agerelated macular degeneration. Surv Ophthalmol 2009;54: 96-117.
66. Lei L, Tzekov R, McDowell JH, Smith WC, Tang S, Kaushal S. Formation of lipofuscin-like material in the RPE Cell by different components of rod outer segments. Exp Eye Res 2013;112:57-67.
67. Kauppinen A, Niskanen H, Suuronen T, Kinnunen K, Salminen A, Kaarniranta K. Oxidative stress activates NLRP3 inflammasomes in ARPE-19 cells-Implications for age-related macular degeneration (AMD). Immunol Lett 2012;147:29-33.
68. Tarallo V, Hirano Y, Gelfand BD, Dridi S, Kerur N, Kim Y, et al. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell 2012;149:847-859.
69. Borras C, Sastre J, Garcia-Sala D, Lloret A, Pallardo FV, Vina J. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol Med 2003;34:546-552.
70. Moor AN, Gottipati S, Mallet RT, Sun J, Giblin FJ, Roque R, et al. A putative mitochondrial mechanism for antioxidative cytoprotection by 17beta-estradiol. Exp Eye Res 2004; 78:933-944.
71. Vina J, Sastre J, Pallardo FV, Gambini J, Borras C. Role of mitochondrial oxidative stress to explain the different longevity between genders: Protective effect of estrogens. Free Radic Res 2006;40:1359-1365.
72. Borras C, Gambini J, Gomez-Cabrera MC, Sastre J, Pallardo FV, Mann GE, et al. 17beta-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFkappaB cascade. Aging Cell 2005;4: 113-118.
73. Nixon E, Simpkins JW. Neuroprotective effects of nonfeminizing estrogens in retinal photoreceptor neurons. Invest Ophthalmol Vis Sci 2012;53:4739-4747.
74. Green PS, Gridley KE, Simpkins JW. Nuclear estrogen receptor-independent neuroprotection by estratrienes: A novel interaction with glutathione. Neuroscience 1998;84: 7-10.
75. Stein B, Yang MX. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol Cell Biol 1995;15:4971-4979.
76. Ray P, Ghosh SK, Zhang DH, Ray A. Repression of interleukin-6 gene expression by 17 beta-estradiol: Inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Lett 1997;409:79-85.
77. Galien R, Garcia T. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NFkappaB site. Nucleic Acids Res 1997;25:2424-2429.
78. Paimela T, Ryhanen T, Mannermaa E, Ojala J, Kalesnykas G, Salminen A, et al. The effect of 17beta-estradiol on IL-6 secretion and NF-kappaB DNA-binding activity in human retinal pigment epithelial cells. Immunol Lett 2007;110: 139-144.
79. Sun WH, Keller ET, Stebler BS, Ershler WB. Estrogen inhibits phorbol ester-induced I kappa B alpha transcription and protein degradation. Biochem Biophys Res Commun 1998;244:691-695.
80. Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM, et al. Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 2000;74:311-317.
81. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997; 277:1508-1510.
82. Filardo EJ, Quinn JA, Bland KI, Frackelton Jr AR. Estrogeninduced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 2000;14: 1649-1660.
83. Thalhamer T, McGrath MA, Harnett MM. MAPKs and their relevance to arthritis and inflammation. Rheumatology (Oxford) 2008;47:409-414.
84. Singer CA, Figueroa-Masot XA, Batchelor RH, Dorsa DM. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 1999;19: 2455-2463.
85. Bruce-Keller AJ, Keeling JL, Keller JN, Huang FF, Camondola S, Mattson MP. Antiinflammatory effects of estrogen on microglial activation. Endocrinology 2000;141: 3646-3656.
86. Reed JL, Dimayuga FO, Davies LM, Keller JN, Bruce-Keller AJ. Estrogen increases proteasome activity in murine microglial cells. Neurosci Lett 2004;367:60-65.
87. Li Y, Wang YS, Shen XF, Hui YN, Han J, Zhao W, et al. Alterations of activity and intracellular distribution of the 20S proteasome in ageing retinal pigment epithelial cells. Exp Gerontol 2008;43:1114-1122.
88. Ryhanen T, Hyttinen JM, Kopitz J, Rilla K, Kuusisto E, Mannermaa E, et al. Crosstalk between Hsp70 molecular chaperone, lysosomes and proteasomes in autophagymediated proteolysis in human retinal pigment epithelial cells. J Cell Mol Med 2009;13:3616-3631.
89. Viiri J, Hyttinen JM, Ryhanen T, Rilla K, Paimela T, Kuusisto E, et al. P62/sequestosome 1 as a regulator of proteasome inhibitor-induced autophagy in human retinal pigment epithelial cells. Mol Vis 2010;16:1399-1414.
90. Viiri J, Amadio M, Marchesi N, Hyttinen JM, Kivinen N, Sironen R, et al. Autophagy activation clears ELAVL1/HuR-mediated accumulation of SQSTM1/p62 during proteasomal inhibition in human retinal pigment epithelial cells. PLoS One 2013;8:e69563.
91. Giddabasappa A, Bauler M, Yepuru M, Chaum E, Dalton JT, Eswaraka J. 17-beta estradiol protects ARPE-19 cells from oxidative stress through estrogen receptor-beta. Invest Ophthalmol Vis Sci 2010;51:5278-5287.
92. Dasari B, Prasanthi JR, Meiers C, Singh BB, Ghribi O. Differential effects of the estrogen receptor agonist estradiol on toxicity induced by enzymatically-derived or autoxidation-derived oxysterols in human ARPE-19 cells. Curr Eye Res 2013;38:1159-1171.
93. Cascio C, Russo D, Drago G, Galizzi G, Passantino R, Guarneri R, Guarneri P. 17beta-estradiol synthesis in the adult male rat retina. Exp Eye Res 2007;85:166-172.
94. Conley YP, Thalamuthu A, Jakobsdottir J, Weeks DE, Mah T, Ferrell RE, et al. Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy. Hum Mol Genet 2005;14:1991-2002.
95. Blasiak J, Glowacki S, Kauppinen A, Kaarniranta K. Mitochondrial and nuclear DNA damage and repair in age-related macular degeneration. Int J Mol Sci 2013;14: 2996-3010.